HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard D Gless Selected Research

1- (1- nicotinoylpiperidin- 4- yl)- 3- (4- (trifluoromethoxy)phenyl)urea

3/2011Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard D Gless Research Topics

Disease

2Hypertension (High Blood Pressure)
03/2011 - 02/2009
1Obesity
03/2011
1Inflammation (Inflammations)
02/2009

Drug/Important Bio-Agent (IBA)

2Epoxide HydrolasesIBA
03/2011 - 02/2009
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2011
1Angiotensin IIIBA
03/2011
11- (1- nicotinoylpiperidin- 4- yl)- 3- (4- (trifluoromethoxy)phenyl)ureaIBA
03/2011
11- (1- acetyl- piperidine- 4- yl)- 3- adamantan- 1- yl- ureaIBA
03/2011
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
03/2011